ArticleAnnals of translational medicine2019
Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?
Hira Latif et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it